2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)

Supriya Chopra; Ekaterina S Jordanova; Nanda Horeweg; Kedar Deodhar; Santosh Menon; Venkatesh Pai; Tynisha Rafael; Umesh Mahantshetty; Barbara Segedin; Nadia Giannakopoulos; Fleur Huang; Kjersti Bruheim; Marga Perz; Bhavana Rai; Li Tee Tan; Maximilian Schmid; Kari Tanderup; Richard Potter; Tjalling Bosse; Remi A Nout

doi:10.1136/ijgc-2022-ESGO.55

Citation Tools

Cervical cancer

2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Chopra S, Jordanova ES, Horeweg N, et al

2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)

International Journal of Gynecologic Cancer 2022;32:A25.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password